Trial Profile
Efficacy and safety of Xience Xpedition everolimus drug eluting stent in patients with long coronary lesions
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jul 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions; Therapeutic Use
- 06 Jul 2017 New trial record